The Lancet Healthy Longevity

The Lancet Healthy Longevity is a monthly gold open access journal published by Elsevier as part of The Lancet Group, launched in 2020 and focused on clinically focused longevity and healthy ageing research, with a 2025 Journal Impact Factor of 20.5《柳叶刀·健康长寿》是由爱思唯尔（Elsevier）作为（The Lancet Group）一部分出版的月刊金色开放获取期刊，2020 年创刊，聚焦以临床为导向的长寿与健康老龄化研究，2025 年影响因子为 20.5。

Scope

• It is a multi-disciplinary journal publishing clinically focused longevity and healthy ageing research and review该刊是多学科期刊，刊载以临床为导向的长寿与健康老龄化研究与综述。
• Its remit spans early stage clinical research into the mechanisms of ageing at any stage of life, and epidemiological and societal research on changing populations其范围涵盖人生各阶段衰老机制的早期临床研究，以及人口结构变化的流行病学与社会研究。
• It includes clinical trials in all disciplines focused, but not exclusively, on older people其涵盖各学科的临床试验，重点关注但不限于老年人群。
• It also covers gerontological science and age specific clinical guidelines该刊还涵盖老年学科学与针对特定年龄的临床指南。
• It publishes clinical and policy reviews that shape and contextualise debate on this fast growing discipline该刊刊载临床与政策综述，旨在塑造并充实这一快速发展的学科的讨论。
• Content types include Articles, Review, Comment, Correspondence and Series内容类型包括论文、综述、评论、通讯与系列专题。

History

• It was launched in 2020 as a gold open access title within The Lancet Group该刊于 2020 年作为（The Lancet Group）旗下的金色开放获取期刊创刊。
• Its first issue appeared in October 2020 as volume 1, issue 1其创刊号于 2020 年 10 月出版，为第 1 卷第 1 期。^[1]
• It was preceded by the gold open access titles eBioMedicine in 2014 and eClinicalMedicine in 2018 in the Lancet family该刊之前，（Lancet）家族分别于 2014 年与 2018 年推出金色开放获取刊（eBioMedicine）与（eClinicalMedicine）。
• In the 2025 Journal Citation Reports it ranks second among 72 journals in geriatrics and gerontology在 2025 年期刊引证报告中，该刊在老年医学与老年学类别的 72 种期刊中位列第二。
• Its Journal Impact Factor moved from 14.6 in 2024 to 20.5 in 2025其影响因子由 2024 年的 14.6 升至 2025 年的 20.5。

Editors

• Its Editor-in-Chief is Philippa Harris现任主编为 Philippa Harris。
• She trained in molecular parasitology and previously served as Deputy Editor of The Lancet HIV and Editor of BMC Infectious Diseases她出身分子寄生虫学，此前曾任（The Lancet HIV）副主编以及（BMC Infectious Diseases）编辑。
• The founding Editor-in-Chief was Cassandra Coburn, who led the journal from its 2020 launch首任主编为 Cassandra Coburn，自 2020 年创刊起领导该刊。
• The in-house editorial team is based in the London office of The Lancet该刊内部编辑团队设于（The Lancet）伦敦办公室。
• Original research is peer reviewed externally for clinical and statistical quality原创研究须经外部临床与统计质量同行评审。
• An international editorial board supports the journal, with members drawn from many countries该刊设有国际编辑委员会，成员来自多个国家。